Post-antibiotic effect of orbifloxacin against Escherichia coli and Pseudomonas aeruginosa isolates from dogs
Open Access
- 20 March 2012
- journal article
- Published by Springer Nature in Acta Veterinaria Scandinavica
- Vol. 54 (1) , 16
Abstract
Orbifloxacin is a fluoroquinolone drug used widely in companion animal medicine. In this study, we firstly determined post-antibiotic effects (PAEs) and post-antibiotic sub-minimum inhibitory concentrations (MIC) effects (PA-SMEs) of orbifloxacin for two strains each of Escherichia coli and Pseudomonas aeruginosa from dogs, and these parameters were compared with those of enrofloxacin. At twice the MIC, the PAEs of orbifloxacin ranged from -0.28-0.93 h (mean, 0.29 h) for E. coli and -0.18-1.18 h (mean, 0.37 h) for P. aeruginosa. These parameters were not significantly different for E. coli and shorter for P. aeruginosa, compared to enrofloxacin (P < 0.05). Continued exposure to 0.1, 0.2, and 0.3 the MIC of orbifloxacin resulted in average PA-SMEs of 0.55, 1.11, and 2.03 h, respectively, for E. coli, and 1.04, 1.40, and 2.47 h, respectively, for P. aeruginosa. These PA-SMEs, which had no significant differences with those of enrofloxacin, were significantly longer than the corresponding PAEs (P < 0.05). These results suggest that the PA-SME of orbifloxacin for E. coli and P. aeruginosa can be meaningfully prolonged by increase of sub-MICs.Keywords
This publication has 10 references indexed in Scilit:
- In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infectionsResearch in Veterinary Science, 2004
- Potency and postantibiotic effect of four fluoroquinolones against feline Pasteurela multocida isolatesVeterinary Record, 2002
- Determination of plasma and skin concentrations of orbifloxacin in dogs with clinically normal skin and dogs with pyoderma.2002
- Activity and postantibiotic effect of marbofloxacin, enrofloxacin, difloxacin and ciprofloxacin against feline Bordetella bronchiseptica isolatesVeterinary Microbiology, 2001
- Pharmacodynamic effects of subinhibitory antibiotic concentrationsInternational Journal of Antimicrobial Agents, 2001
- In Vitro Activity of Difloxacin against Canine Bacterial IsolatesJournal of Veterinary Diagnostic Investigation, 2000
- Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 1997
- Absorption, Distribution and Excretion of Orbifloxacin in Dogs and CatsJournal of the Japan Veterinary Medical Association, 1997
- Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolatesJournal of Veterinary Pharmacology and Therapeutics, 1995
- In VitroPostantibiotic Effect and Postantibiotic Leukocyte Enhancement of TobramycinJournal of Chemotherapy, 1995